Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Remarkable complete pathologic response rate after preoperative paclitaxel, gemcitabine, and trastuzumab chemotherapy in HER2 positive stage III/III breast cancer: a phase II multicenter study.
- Authors
- Im, SA[Im, S-A]; Lee, KS[Lee, K. S.]; Lee, ES[Lee, E. S.]; Kwon, Y[Kwon, Y.]; Noh, DY[Noh, D-Y]; Park, IA[Park, I-A]; Ahn, JH[Ahn, J-H]; Ahn, JS[Ahn, J. S.]; Kim, JH[Kim, J. H.]; Nam, BH[Nam, B-H]; Ro, J[Ro, J.]
- Issue Date
- 15-Jan-2009
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- CANCER RESEARCH, v.69, no.2, pp.331S - 332S
- Indexed
- SCIE
SCOPUS
- Journal Title
- CANCER RESEARCH
- Volume
- 69
- Number
- 2
- Start Page
- 331S
- End Page
- 332S
- ISSN
- 0008-5472
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.